Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

被引:0
作者
K Gündüz
S J Bakri
机构
[1] Mayo Clinic,Department of Ophthalmology
来源
Eye | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1168 / 1171
页数:3
相关论文
共 62 条
[1]  
Rosenfeld PJ(2005)Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmic Surg Lasers Imaging 36 331-335
[2]  
Mosfeghi AA(2006)Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363-372
[3]  
Puliafito CA(2006)Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy Ophthalmology 113 1695-1705
[4]  
Avery RL(2006)Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short term study Retina 26 279-284
[5]  
Pieramici D(2006)Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema Retina 26 356-357
[6]  
Rabena M(1984)Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 271-282
[7]  
Castellarin AA(2007)Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 114 855-859
[8]  
Nasir MA(2003)Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 681-686
[9]  
Giust MJ(2007)Pharmacokinetics of intravitreal ranibizumab (Lucentis) Ophthalmology 114 2179-2182
[10]  
Avery RL(2005)Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion Retina 25 851-858